Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

REBOXETINE vs REMDESIVIR: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

REBOXETINE vs REMDESIVIR: Safety Overview

Metric REBOXETINE REMDESIVIR
Total FAERS Reports 185 10,501
Deaths Reported 19 2,729
Death Rate 10.3% 26.0%
Hospitalizations 63 2,556
Average Patient Age 53.6 yrs 61.7 yrs
% Female Patients 62.7% 39.8%
FDA Approval Date N/A Oct 22, 2020
Manufacturer N/A Gilead Sciences, Inc.
Route N/A INTRAVENOUS
Marketing Status N/A Prescription